Study S001043

Real World Effectiveness of Oral Semaglutide in Thailand Patients With Type 2 Diabetes: an Observational, Multicentre, Retrospective Cohort Study REAL-world Effectiveness of Oral Semaglutide In a Cohort of Thai patientS With Type 2 Diabetes treatED With Oral Antidiabetic Medications (REALISED) Study

ClinicalTrials.gov record

Registration

Registration: NCT06507475
Acronym: REALISED
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 209
Start: 2024-09-07
Primary completion: 2024-12-20
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1294-2999

Registered primary outcomes

Change in Glycated Haemoglobin (HbA1c) [Baseline (week 0), end of study (week 26)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.